Wegovy 1mg: clearing up the confusion around this dose

The misconception worth correcting: 1mg is not a 'starter' or a 'low' dose

A common misreading is that 1.0mg Wegovy is weak, introductory, or somehow insufficient. That framing is understandable (the number feels small) but it misses why the titration schedule exists at all. The earlier doses (0.25mg and 0.5mg) are there to let your digestive system adjust before the medicine reaches levels where its appetite effects are more pronounced. By the time you reach 1.0mg, your body has usually had eight weeks to acclimatise. It is genuinely a mid-point, not a start.

That said, 1.0mg is not a therapeutic endpoint either. Clinical trials for Wegovy were designed around 2.4mg as the maintenance dose, and the significant average weight reductions (roughly 15% of body weight over 68 weeks in the STEP 1 trial, published in the New England Journal of Medicine) were measured at that level. The 1.0mg step is doing a specific job: extending tolerability while moving the dose forward. It is neither a failure nor a final answer.

People sometimes plateau at 1.0mg and worry treatment has stopped working. That concern is worth raising with your prescriber, not sitting with quietly. Titration timing and any pause in progression are clinical decisions, the Patient Information Leaflet and your prescribing team are the right sources, not generalised online guidance.

What changes (and what does not) as you move through the dose steps

At each step up the Wegovy ladder, the semaglutide concentration increases and, for many people, so does the appetite-reducing effect. Gastric emptying slows a little more; the feeling of fullness after smaller meals tends to deepen. Most gastrointestinal side effects (nausea, loose stools, indigestion) are most noticeable in the first week or two after a dose increase, then typically settle. This pattern tends to repeat at each step, including the move to 1.0mg.

What does not change is the once-weekly injection schedule. The pen design and injection technique stay the same throughout titration. Injection sites (abdomen, outer thigh, upper arm) should be rotated each week regardless of dose. Storage requirements stay constant too: if you want to understand exactly how the Wegovy 1ml pen is supplied and stored, that detail is covered on its own page. And if you have questions about how the Wegovy 1mg dose fits into the overall titration sequence, that page goes into the specifics.

The full Wegovy overview on this site covers the mechanism, the licensed indications, and the eligibility criteria in more detail. For a closer look at how individual dose levels compare in practice, the semaglutide information page is a useful next read.

Who decides when to move from 1.0mg to the next step?

That decision belongs to your prescriber, not to a number on a pen. Guidance from the NHS semaglutide medicines page is clear that dose increases follow clinical review, weighing up tolerability and response. A prescriber will generally consider whether side effects from the current dose have settled, whether there are any clinical reasons to hold, and whether your weight trend supports moving forward.

At nume, every dose increase goes through fresh clinical review before anything is dispensed. A named GPhC-registered prescriber reads your case, not software, not an automated system. If you are transferring from another provider and are already on 1.0mg, you will be asked to provide evidence of your current dose before any continuation is arranged.

For people thinking about what comes after 1.0mg, the 1.7mg and 2.4mg dose stages are covered separately. And if you are exploring where treatment might lead over time, our weight-loss treatment overview maps out the broader picture, including how lifestyle changes sit alongside the medicine.

The cost question, and what it means at the 1.0mg stage

Wegovy is a private prescription medicine for most people in the UK right now, and cost is a reasonable thing to think about. The price you pay should include consultation, clinical review, prescription and delivery, not just the pen itself. What headline prices sometimes leave out is the ongoing prescriber access that dose titration requires. It is worth knowing what you are actually paying for before committing.

We cover the cost of Wegovy in the UK in straightforward terms, including what legitimate private treatment involves and why checking a pharmacy on the GPhC register matters before you buy from anyone. If you are weighing up whether Wegovy is the right route for you, starting with a free consultation is the lowest-friction way to find out.